Finance
AstraZeneca pursues merger with Bristol Myers Squibb
AstraZeneca is seeking a merger with US pharmaceutical firm Bristol Myers Squibb, raising antitrust concerns and driving a nine percent drop in its shares.
MarketsIndicesCommoditiesFXRates
